The Precision Peptide Company Inc.
BPC
CNSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -459.23% | -329.85% | -56.99% | 12.23% | 33.45% |
| Total Depreciation and Amortization | 3,373.68% | 2,438.46% | 2,800.00% | -57.14% | -32.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,547.29% | 924.36% | -83.88% | -62.18% | -60.58% |
| Change in Net Operating Assets | -2.70% | -4.11% | 419.37% | 149.13% | 583.31% |
| Cash from Operations | -404.12% | -295.43% | 14.16% | 41.58% | 62.31% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 355.66% | 461.80% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 351.35% | 437.15% | 894.76% | 124.97% | -50.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 366.96% | 441.48% | 856.09% | 118.92% | -48.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 200.00% | -- | -- |
| Net Change in Cash | 48.08% | 831.99% | 1,036.21% | 154.58% | 595.12% |